Skip to main content
Equibles

Michael DeFore

Analyst

Evercore ISI

Equibles does not estimate personal net worth.

About Michael DeFore

Michael DeFore is recorded as Analyst at Evercore ISI. Michael DeFore has spoken on 1 earnings call and 1 other investor event across 2 companies, most recently for Biogen Inc. on July 14, 2026. Those appearances were for Biogen Inc. (BIIB) and Tg Therapeutics, Inc. (TGTX). The companies whose calls Michael DeFore spoke on are classified in the Healthcare sector.

Michael DeFore on recent calls

“Number one, what could explain the disconnect between towel lowering and clinical response? You think that the PD effect and clinical response would be positively correlated, but we saw the opposite.”
Analyst — Evercore ISI, Biogen at the Alzheimer's Association International Conference (AAIC) 2026 ·
“Roche has recently highlighted accelerating sub-Q uptake in community practices, and Novartis continues to emphasize strong growth in self-administered first-line use.”
Analyst — Evercore ISI, Tg Therapeutics, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • Evercore ISI

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity